MSX-3
MSX-3
The MSX-3 is a standard for home computers that was announced in the early 1990s as a successor to the MSX-2+ standard. The MSX-3 was intended to further enhance the capabilities of the MSX computer line, which was popular in Japan and several other countries during the 1980s and early 1990s. However, the MSX-3 standard was never fully realized in the form of a commercial product, and it remains a part of the MSX legacy as a concept rather than a widely adopted platform.
History
The MSX standard was originally conceived by Kazuhiko Nishi of ASCII Corporation and Microsoft in the early 1980s. The goal was to create a unified standard for home computers, allowing software and hardware compatibility across different manufacturers. The first MSX computers were released in 1983, followed by the improved MSX-2 in 1985 and the MSX-2+ in 1988.
The MSX-3 was announced as the next step in the evolution of the MSX standard. It was expected to include advanced features such as enhanced graphics and sound capabilities, improved processing power, and expanded memory. However, by the time the MSX-3 was being developed, the home computer market was rapidly changing, with the rise of IBM PC compatible computers and other platforms.
Features
The proposed features of the MSX-3 included:
- Advanced Graphics: The MSX-3 was expected to support higher resolution graphics and more colors than its predecessors, potentially incorporating new video display processors.
- Improved Sound: Enhanced sound capabilities were planned, possibly including support for more sound channels and higher quality audio output.
- Increased Memory: The MSX-3 was to have more memory available for both system and user applications, allowing for more complex software.
- Backward Compatibility: Like previous MSX standards, the MSX-3 was intended to maintain compatibility with earlier MSX software and hardware.
Legacy
Although the MSX-3 standard was never fully implemented, it remains a topic of interest among MSX enthusiasts and historians. The MSX community continues to develop and support the platform through emulation, software development, and hardware projects.
The MSX-3 concept represents an important part of the MSX story, highlighting the ambitions of the MSX standard to continue evolving in the face of a rapidly changing technology landscape.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD